Facebook
X
LinkedIn
Forward| Title | Credit |
Series date |
Member price | Non-member price |
|---|---|---|---|---|
|
Endocrine Emergencies in the Pediatric ICU 2024 1.0 NAPNAP Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $10 for NAPNAP Members. For non-members, this continuing education activity rate is $20. This course is a recorded presentation for NAPNAP's 2024 National Conference. Pediatric endocrine emergencies outside of diabetic ketoacidosis are relatively uncommon. When they do present these children are at risk for significant morbidities if not recognized and treated appropriately. This presentation will discuss a series of three endocrinologic diagnostic challenges in the Pediatric Intensive Care Unit. |
|
06/27/2024 to 06/30/2026 | $10.00 | $20.00 |
|
Antiviral Therapeutics for Pediatric Primary and Acute Care 2024 Offers 1.0 contact hour, of which 1.0 is pharmacology content and is free for members until February 28, 2025. 1.0 NAPNAP Contact Hour, of which 1.0 is pharmacology content. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $10 for NAPNAP Members. For non-members, this continuing education activity rate is $20. This course is a recorded presentation for NAPNAP's 2024 National Conference. Viral illness is common in the pediatric population, and antiviral therapies are available for prevention or treatment of select viruses. This presentation will review antiviral medications commonly used in pediatric primary and acute care, including targeted populations, efficacy data and current guidance. |
|
06/27/2024 to 06/30/2026 | $10.00 | $20.00 |
|
Tick Talk: Digging Deeper into Lyme Disease 2024 1.0 NAPNAP Contact Hour. This continuing education activity is free to National Association of Pediatric Nurse Practitioners (NAPNAP) members and non-members. This course is a recorded presentation for NAPNAP's 2024 National Conference. Lyme disease is the most common vector-borne disease in the U.S., with a childhood peak at five to nine years of age. Pediatric-focused APRNs in both high and low incidence areas may encounter patients in whom Lyme disease is a concern. This presentation will provide an in-depth review of Lyme disease testing and interpretation, discuss when (and when not) to treat and examine the current knowledge regarding prolonged symptoms. |
|
06/27/2024 to 06/30/2026 | $0.00 | $0.00 |
|
2024 National Conference on Pediatric Health Care Bundle SAVE You get 24 courses from NAPNAP's 2024 National Conference totaling 27 NAPNAP Contact Hours, 5.5 Pharmacology,1.25 Psychopharmacology and 2.5 Controlled Substance. This continuing education activity is offered at a member-only discounted rate of $199, a cost-savings of more than $60. Non-members may purchase this bundle for $500. Join NAPNAP before purchasing to save more than $300. |
06/30/2024 to 06/30/2026 | $199.00 | $199.00 | |
|
Mandated Reporting 1.0 NAPNAP contact hour. This continuing education activity is offered FREE to Members and Nonmembers. Should I report my concerns for suspected child maltreatment and neglect? If I do report, how do I know how and what to report? The NAPNAP Child Maltreatment and Neglect SIG discusses key factors in the various typologies of abuse for pediatric-focused advanced practice nurses in determining the need and steps to report child maltreatment and neglect. |
|
06/01/2025 to 06/01/2026 | $0.00 | $0.00 |
|
Navigating Pediatric Obesity Treatment: Exploring the Latest AAP Guidelines and Strategies 1.0 NAPNAP contact hour of which 0.25 contain pharmacology content. This continuing education activity is offered FREE to Members and Nonmembers. The purpose of this program is to inform primary care pediatric health care providers about the management of children and adolescents with obesity guided by the American Academy of Pediatrics (AAP) Clinical Practice Guidelines published in 2023. The presentation content focuses on how to implement best practices for the management of children and adolescents with obesity including pharmacotherapy. Additionally, guidance on the AAP resources and how to access and utilize these tools will be discussed. |
|
05/17/2024 to 05/31/2026 | $0.00 | $0.00 |
|
Childhood Obesity SIG Course Bundle In this course bundle, three courses have been selected by the Childhood Obesity Prevention Special Interest Group (CO SIG) to increase knowledge related to AAP's 2023 Clinical Practice Guideline for the Evaluation and Treatment of Pediatric Obesity in Primary Care. |
05/16/2025 to 05/31/2026 | $0.00 | $0.00 | |
|
Guidance for Primary Care PNPs During and After Medical/Surgical Treatment of Obesity in Adolescents 1.0 NAPNAP contact hour. This continuing education activity is offered FREE to Members and Nonmembers. The American Academy of Pediatrics (AAP) recently released the ‘Clinical Practice Guideline (CPG) for the Evaluation and Treatment of Children and Adolescents with Obesity’ in early 2023. Updated from the AAP’s 2008 recommendations for prevention, assessment, and treatment of children and adolescents with overweight and obesity, the 2023 CPG offers expanded treatment recommendations which includes medication and surgical management. Pediatric Nurse Practitioners (PNP) may not understand the long-term management and support needs in primary care needed for this population. Discussion of management considerations for the primary care provider include: preventative care and screenings, health promotion, nutrition, body image, physical activity and psychological support. Additionally, recommendations for family and community involvement to support improved long-term care outcomes will be discussed. |
|
05/17/2024 to 05/31/2026 | $0.00 | $0.00 |
|
Clinical Updates in Pediatric Food Allergy Management Pediatric nurse practitioners and others who care for children with FA will benefit from a review of the immunopathophysiology and diagnosis of immunoglobulin E (IgE)-mediated FA and available therapies and data related to the use of biologic therapy in this disease. Experts will discuss the key aspects of FA management and contextualize the information in nurse practitioners’ role in important patient and caregiver conversations and care. |
|
05/15/2025 to 05/15/2026 | $0.00 | $0.00 |
|
JPHC CE: Approaches to Treating Children With ADHD and Common Comorbidities 1.0 NAPNAP contact hour of which 1.0 contain pharmacology content (Rx), (1.0 is related to psychopharmacology), (0.25 is related to controlled substance). This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10. Attention Deficit Hyperactivity Disorder (ADHD) is the most common mental health disorder among children and adolescents, with a prevalence rate of 9.8% in children 3 to 17 years of age (Bitsko et al., 2022). The American Academy of Pediatrics (AAP) has published guidelines for treatment of ADHD in children and adolescents ages 4 to 17 years that address diagnosis, treatment and monitoring of ADHD (Wolraich et al., 2019). The AAP guidelines do not address treatment of children with co-morbidities but identify the treatment of ADHD in children with comorbidities as an area for future research. To address this gap, a review of ADHD treatment in children with comorbidities including anxiety, depression, substance use disorder (SUD), epilepsy, tic disorders (TD), oppositional defiant disorder (ODD), learning disabilities (LD), autism spectrum disorder (ASD) and sleep disorders was conducted. J Pediatr Health Care. (2025) 39, 318-325. |
|
03/01/2025 to 04/30/2026 | $0.00 | $10.00 |
|
JPHC CE: Preventing Suicide Through Lethal Means Restriction in Pediatric Care 1.0 NAPNAP contact hour. This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10. This article explores the data and practice evidence for lethal means restriction and counseling, focusing on clinical strategies and policy changes to reduce access to lethal means. Emphasis is given to how pediatric providers speak with parents about the importance of restricting access when developing a safety plan. J Pediatr Health Care. (2025) 39, 308-317. |
|
03/01/2025 to 04/30/2026 | $0.00 | $10.00 |
|
2025 Immunization Update 1.25 NAPNAP Contact Hour of which 1.25 contain pharmacology content. This continuing education activity is offered free for NAPNAP Members. For non-members, this continuing education activity rate is $12.50. While presenting the latest CDC immunization information, Dr. Koslap-Petraco will share real life experiences and case studies to engage and challenge you to educate and vaccinate your patient families, especially those who question the need for vaccines. |
|
04/07/2025 to 04/30/2026 | $0.00 | $12.50 |
|
Stop Child Trafficking in Your Community: Become an ACT Advocate (2024) 1.5 NAPNAP Contact Hours. This continuing education activity rate is $30 for NAPNAP Members and for non- members. This life-saving, innovative workshop and leadership opportunity is specifically developed for pediatric focused NPs to learn about child trafficking, methods of identification and referral and, most importantly, prevention. There are more people enslaved in labor and/or sex trafficking than at any point in history, meaning children of all socio-economic profiles are at risk with some populations more vulnerable than others. Alliance for Children in Trafficking (ACT) Advocates will receive a certificate of recognition as a trained expert who will then be able to deliver this unique content to health care professionals and lay people in your community. |
|
03/21/2024 to 03/31/2026 | $30.00 | $30.00 |
|
JPHC CE: Gene Therapy: A New Hope in Sickle Cell Disease Treatment 1.0 NAPNAP contact hour of which 1.0 contain pharmacology content. This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10. Sickle cell disease (SCD) is a lifelong disease requiring expensive treatment for management and limited curative options until the last few years. Gene therapy has emerged as a curative option for SCD, with two approved therapies available to SCD patients aged greater than 12 years. Consideration must be considered regarding the ethics, efficacy, management requirements, education, and counseling needs of patients and their parents. Current and future practices will need to advocate for improved access and affordability of this specialized care and address the unknown and less defined areas of gene therapy pertaining to SCD through research. J Pediatr Health Care. (2025) 39, Issue 1, 122-128. |
|
01/01/2025 to 02/28/2026 | $0.00 | $10.00 |
|
PIDS: Antimicrobial Stewardship for Advanced Practice Providers 0.5 NAPNAP Contact Hour. This continuing education activity is offered free to NAPNAP Members and for non- members. This session will highlight the key concepts related to antimicrobial stewardship for Advanced Practice Providers in the outpatient environment. Learn the core strategies to combat the threat of antimicrobial resistance. Improving antibiotic use amongst all providers is a key component in reducing inappropriate antimicrobial use and antibiotic resistance. |
|
11/30/2023 to 12/31/2025 | $0.00 | $0.00 |